ALGS

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Aligos Therapeutics Inc

NASDAQ | ALGS

9.21

USD

$0.00

(

0.00%

)

At Close (As of Dec 2, 2025)

$57.23M

Market Cap

-

P/E Ratio

-13.54

EPS

$46.80

52 Week High

$3.76

52 Week Low

HEALTHCARE

Sector

ALGS Chart

Recent Chart
Price Action

ALGS Technicals

Tags:

ALGS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.9M
Total Revenue $3.9M
Cost Of Revenue $2.6M
Costof Goods And Services Sold $2.6M
Operating Income -$89M
Selling General And Administrative $23M
Research And Development $70M
Operating Expenses $93M
Investment Income Net -
Net Interest Income $4.4M
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.6M
Income Before Tax -$131M
Income Tax Expense $331K
Interest And Debt Expense -
Net Income From Continuing Operations -$131M
Comprehensive Income Net Of Tax -
Ebit -$89M
Ebitda -$87M
Net Income -$131M

Revenue & Profitability

Earnings Performance

ALGS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $70M
Total Current Assets $62M
Cash And Cash Equivalents At Carrying Value $37M
Cash And Short Term Investments $37M
Inventory -
Current Net Receivables -
Total Non Current Assets $8M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $20M
Other Current Assets $5.2M
Other Non Current Assets -
Total Liabilities $99M
Total Current Liabilities $22M
Current Accounts Payable $2.6M
Deferred Revenue -
Current Debt -
Short Term Debt $3.5M
Total Non Current Liabilities $79M
Capital Lease Obligations $8.4M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $8.4M
Other Current Liabilities $16M
Other Non Current Liabilities $46K
Total Shareholder Equity -$29M
Treasury Stock -
Retained Earnings -$618M
Common Stock $8K
Common Stock Shares Outstanding $6.3M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$81M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $2.6M
Capital Expenditures $130K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$18M
Cashflow From Financing $355K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$131M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.9M
Total Revenue $3.9M
Cost Of Revenue $2.6M
Costof Goods And Services Sold $2.6M
Operating Income -$89M
Selling General And Administrative $23M
Research And Development $70M
Operating Expenses $93M
Investment Income Net -
Net Interest Income $4.4M
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.6M
Income Before Tax -$131M
Income Tax Expense $331K
Interest And Debt Expense -
Net Income From Continuing Operations -$131M
Comprehensive Income Net Of Tax -
Ebit -$89M
Ebitda -$87M
Net Income -$131M

ALGS News

ALGS Profile

Aligos Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Aligos Therapeutics, Inc. (ALGS) is a dynamic clinical-stage biopharmaceutical company based in South San Francisco, California, focused on developing innovative therapies for viral infections and liver diseases. Its extensive pipeline features candidates for chronic hepatitis B and liver fibrosis, underscoring the company's commitment to addressing critical unmet medical needs through advanced scientific approaches and strategic collaborations. Aligos's dedication to pioneering transformative healthcare solutions positions it as a compelling investment opportunity for institutional investors seeking growth in the biopharmaceutical sector.

LPTX
+368.57%
$2.05
BYND
+36.48%
$1.34
PAVS
-29.35%
$0.05
VHAI
0.00%
$0.00
NVDA
+0.85%
$181.46
PLRZ
+130.56%
$7.28
INTC
+8.97%
$43.60
FTEL
+0.15%
$1.20
PLUG
+9.89%
$2.11
CMND
-9.93%
$0.12
BITF
-5.48%
$3.10
ONDS
+6.46%
$8.07
IPG
-1.95%
$24.57
IREN
-15.19%
$41.12
TSLA
-0.20%
$429.24
AXDX
-61.36%
$0.03
BMNR
+10.19%
$31.89
SOFI
+1.65%
$29.51
NIO
-5.81%
$5.18
AAL
+2.18%
$14.26
F
-1.55%
$12.95
BBD
+1.24%
$3.66
ASST
-0.42%
$1.04
BURU
-8.63%
$0.22
ADAP
-15.14%
$0.05
CLSK
-6.75%
$14.08
BMNU
-24.98%
$6.14
BTBT
-5.46%
$2.25
AAPL
+1.52%
$283.10
SNAP
-0.52%
$7.64
WBD
+2.76%
$24.53
AMZN
+0.23%
$234.42
DNN
+2.97%
$2.59
PFE
-0.47%
$25.15
SOND
-23.45%
$0.12
GOOGL
-1.65%
$314.89
YGMZ
-21.06%
$0.08
ACHR
+3.68%
$7.73
IRBT
+6.96%
$1.69
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
MARA
+5.16%
$12.11
ADD
-25.47%
$0.05
BTG
-0.43%
$4.60
ITUB
+2.73%
$7.90
CIFR
-10.41%
$17.64
PLTR
+1.91%
$170.69
IVP
-0.62%
$0.12
SRM
+53.27%
$10.30
ABEV
0.00%
$2.57
CAN
-6.15%
$0.94
MRVL
+1.96%
$92.89
RIG
-1.36%
$4.35
EXK
-1.70%
$9.24
APLD
-0.56%
$28.05
HOOD
-4.08%
$123.24
INHD
-15.40%
$0.14
MSTR
+5.78%
$181.33
PLTD
-1.83%
$6.96
KVUE
-2.17%
$16.84
AMD
+1.02%
$219.76
BAC
-0.76%
$53.24
SGMO
+3.47%
$0.44
VALE
+1.65%
$12.90
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
RIVN
+1.20%
$17.36
HBAN
+0.12%
$16.56
WULF
-4.24%
$14.65
NFLX
+0.20%
$109.35
CRWV
-1.28%
$76.07
GPUS
+6.41%
$0.28
AFMD
-34.94%
$0.18
CPNG
-5.36%
$26.65
IXHL
+12.12%
$0.39
VZ
-0.29%
$40.62
GOOG
+0.28%
$316.02
TMC
+17.74%
$7.40
CHR
-0.91%
$0.04
AG
+2.48%
$15.90
RGTI
+1.89%
$23.89
AVGO
-1.16%
$381.57
SOUN
-2.60%
$11.22
HL
+2.54%
$17.53
XYZ
-6.58%
$60.11
BTE
0.00%
$3.22
DRCT
-15.28%
$0.10
T
-1.06%
$25.51
KO
-1.77%
$70.67
NOK
+1.22%
$6.19
PCG
-2.87%
$15.38
TAOP
+32.71%
$2.84
ORCL
+0.06%
$201.08
VICI
-0.52%
$28.44
AUR
-4.77%
$3.99
IBRX
-2.54%
$2.30
CGC
-1.76%
$1.11
GRYP
-10.38%
$1.38
SMR
+4.75%
$18.94
RIOT
-0.71%
$15.36
LPTX
+368.57%
$2.05
BYND
+36.48%
$1.34
PAVS
-29.35%
$0.05
VHAI
0.00%
$0.00
NVDA
+0.85%
$181.46
PLRZ
+130.56%
$7.28
INTC
+8.97%
$43.60
FTEL
+0.15%
$1.20
PLUG
+9.89%
$2.11
CMND
-9.93%
$0.12
BITF
-5.48%
$3.10
ONDS
+6.46%
$8.07
IPG
-1.95%
$24.57
IREN
-15.19%
$41.12
TSLA
-0.20%
$429.24
AXDX
-61.36%
$0.03
BMNR
+10.19%
$31.89
SOFI
+1.65%
$29.51
NIO
-5.81%
$5.18
AAL
+2.18%
$14.26
F
-1.55%
$12.95
BBD
+1.24%
$3.66
ASST
-0.42%
$1.04
BURU
-8.63%
$0.22
ADAP
-15.14%
$0.05
CLSK
-6.75%
$14.08
BMNU
-24.98%
$6.14
BTBT
-5.46%
$2.25
AAPL
+1.52%
$283.10
SNAP
-0.52%
$7.64
WBD
+2.76%
$24.53
AMZN
+0.23%
$234.42
DNN
+2.97%
$2.59
PFE
-0.47%
$25.15
SOND
-23.45%
$0.12
GOOGL
-1.65%
$314.89
YGMZ
-21.06%
$0.08
ACHR
+3.68%
$7.73
IRBT
+6.96%
$1.69
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
MARA
+5.16%
$12.11
ADD
-25.47%
$0.05
BTG
-0.43%
$4.60
ITUB
+2.73%
$7.90
CIFR
-10.41%
$17.64
PLTR
+1.91%
$170.69
IVP
-0.62%
$0.12
SRM
+53.27%
$10.30
ABEV
0.00%
$2.57
CAN
-6.15%
$0.94
MRVL
+1.96%
$92.89
RIG
-1.36%
$4.35
EXK
-1.70%
$9.24
APLD
-0.56%
$28.05
HOOD
-4.08%
$123.24
INHD
-15.40%
$0.14
MSTR
+5.78%
$181.33
PLTD
-1.83%
$6.96
KVUE
-2.17%
$16.84
AMD
+1.02%
$219.76
BAC
-0.76%
$53.24
SGMO
+3.47%
$0.44
VALE
+1.65%
$12.90
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
RIVN
+1.20%
$17.36
HBAN
+0.12%
$16.56
WULF
-4.24%
$14.65
NFLX
+0.20%
$109.35
CRWV
-1.28%
$76.07
GPUS
+6.41%
$0.28
AFMD
-34.94%
$0.18
CPNG
-5.36%
$26.65
IXHL
+12.12%
$0.39
VZ
-0.29%
$40.62
GOOG
+0.28%
$316.02
TMC
+17.74%
$7.40
CHR
-0.91%
$0.04
AG
+2.48%
$15.90
RGTI
+1.89%
$23.89
AVGO
-1.16%
$381.57
SOUN
-2.60%
$11.22
HL
+2.54%
$17.53
XYZ
-6.58%
$60.11
BTE
0.00%
$3.22
DRCT
-15.28%
$0.10
T
-1.06%
$25.51
KO
-1.77%
$70.67
NOK
+1.22%
$6.19
PCG
-2.87%
$15.38
TAOP
+32.71%
$2.84
ORCL
+0.06%
$201.08
VICI
-0.52%
$28.44
AUR
-4.77%
$3.99
IBRX
-2.54%
$2.30
CGC
-1.76%
$1.11
GRYP
-10.38%
$1.38
SMR
+4.75%
$18.94
RIOT
-0.71%
$15.36
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.